|
|
|
|
|
|
By Eric Doerr, Sanofi, Toronto | Part two of this series digs into real-world examples from Sanofi for getting the right stakeholders on board when altering a process or changing equipment. |
|
|
|
|
|
|
| Tackling Cell And Gene Therapy Manufacturing Challenges | White Paper | By Peggy Tseng and Tsung-Ting Tsai, Mycenax | Allogeneic therapies are gaining popularity due to diversity, scalability, and affordability. A partner with innovative solutions can help streamline the path from discovery to commercialization. |
|
|
| What To Expect From Your First CMO Remote Audit | Article | Argonaut Manufacturing Services | Choosing the right manufacturing partner means going beyond just technical specs. Viewing the facility layouts and conditions is critical. Now is the time to familiarize yourself with remote auditing. |
|
|
| Mitigating Nitrosamine Risks In Pharmaceuticals | White Paper | Alcami | Nitrosamines can come from a range of sources, including raw materials, manufacturing processes, and even water sources. Detecting them requires sensitive analytical methods. |
|
|
| Reducing Commercial Manufacturing Risks | Article | By Cyrill Kellerhals, Andelyn Biosciences | For any biotherapeutic in development today, a critical element in achieving commercialization is reducing manufacturing risk. |
|
|
|
|
| Connect with researchers from around the world for a deep dive into solutions for optimizing bioprocessing, and immerse yourself at the forefront of innovation at CHI's Bioprocessing Summit. Leaders from top pharma, biotech, academic, and governmental institutions will convene on August 19-22 in Boston and online for cutting-edge presentations, live breakout groups, poster sessions, collaboration, networking, and more. Learn more at BioprocessingSummit.com. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Complex protein-based therapies don’t play by the same process-engineering rules as small molecules and traditional biologics. They require developers to see the unforeseen and embrace new roles and responsibilities in sourcing raw materials and outsourced expertise. Successful developers can’t let this winding road slow their time to IND. Join Bioprocess Online Live on August 8th for an interactive discussion on early workflow considerations for complex protein-based therapeutics. Supported by Thermo Fisher Scientific. |
|
|
Connect With Bioprocess Online: |
|
|
|